Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 65% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 8/9 — financially strong with improving fundamentals
- ROE of 4.4% — below-average profitability
Alcon Inc. Ordinary Shares (ALC) is a Healthcare company operating in Ophthalmic Goods, listed on the NYSE , with a market capitalisation of $36.3 billion . Key value metrics: P/E ratio 37.1, P/B ratio 1.65, Piotroski F-Score 8 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Alcon Inc. Ordinary Shares — Fundamental Analysis Summary
Alcon Inc. Ordinary Shares (ALC) is currently trading 65% above its Graham Number of $45.22, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 37.1x.
On financial health, ALC shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 4.4% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.22.
StockPik's composite Value Score for ALC is 67/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ALC reports a solid gross margin of 55.9% (sector average: 33.5%) and a solid operating margin of 13.1%.
ALC shows revenue growing at 5% year-over-year, with earnings declining at 4%.